SZSofia Gambigliani Zoccoli

Sofia Gambigliani Zoccoli

*This is an algorithmically generated author record based on publicly available information.

Sofia Gambigliani Zoccoli has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The ultrasound-based #Enzian classification as a prognostic tool for fertility in women with endometriosis: a real-world cohort study

    by Carlo Alboni, Sofia Gambigliani Zoccoli, Nunzia Del Villano, Martina Di Gianvito, Riccardo Costantini Cuoghi, Matilde Morini, Maria Rosaria Campitiello, Marianna Cannoletta, Antonino Farulla, Emma Bertucci, et al.

    PurposeTo evaluate whether the ultrasound-based #Enzian classification provides prognostic information on fertility in women with endometriosis, and whether it can be used as a tool for individualized counselling regarding the likelihood of spontaneous and ART-assisted conception.MethodsWe conducted a retrospective cohort study at a tertiary referral center (2018-2023). From 723 women with endometriosis, 78 met the inclusion criteria: ultrasound-confirmed disease, active desire for pregnancy, and no hormonal therapy or surgery at baseline. Patients were followed for a median of 48 months (range 14-60). Clinical, sonographic, reproductive, and surgical data were collected. Associations between #Enzian compartments and pregnancy outcomes were analysed using Cox regression adjusted for male factor infertility.ResultsFifty-five of 78 women (70.5%) achieved pregnancy, with a live birth (LB) rate of 44.9% and a median time to pregnancy (TTP) of 24 months, confirming subfertility in this population. Among them, 36 conceived spontaneously and 19 through ART. During follow-up, 36 women (46.2%) underwent surgery after failed spontaneous attempts and worsening symptoms; 19 conceived postoperatively, resulting in 15 LB, with a median TTP of 36 months. Adenomyosis (F.A) and right tubo-ovarian adhesions (T.right) were significantly associated with reduced pregnancy rates (HR 0.27 and 0.74, respectively) and both negatively influenced ART success (HR for F.A 0.25). Compartment A (rectovaginal space and vagina) involvement was linked to significantly longer TTP (+10.2 months, p=0.020).ConclusionWomen with endometriosis are subfertile, with prolonged TTP and reduced LB rates. The ultrasound-based #Enzian classification provides compartment-specific prognostic information, supporting its role as a non-invasive tool to refine fertility counselling and guide clinical management.

  • The #Enzian Classification as a Predictor of Hormonal Therapy Response in Endometriosis-Associated Pain: A Retrospective Cohort Study in a Referral Center

    by Sofia Gambigliani Zoccoli, Antonio La Marca, Martina Di Gianvito, Riccardo Cuoghi Costantini, Matilde Morini, Emma Bertucci, Carlo Alboni

    Objectives: The objective of this study was to evaluate whether ultrasound-based #Enzian classification predicts pain profiles and response to hormonal therapy in patients with endometriosis. Endometriosis is a chronic inflammatory disease affecting 10% of reproductive-age women, often causing debilitating pelvic pain. Although #Enzian is validated for surgical planning, its predictive role in medical therapy remains unexplored. Design: A retrospective cohort study, including 89 premenopausal patients referred between 2018 and 2023, was conducted. Hormonal therapies included progestin-only pills (dienogest – POP-D or other progestins – POP-O), combined estrogen-progestin pills (dienogest – EP-D or other EP-O), or norethisterone acetate. Pain was assessed via a 0–10 VAS at baseline, ≥3 months, and ≥6 months. Participants/Materials, Setting, Methods: Patients had ultrasound-confirmed endometriosis and were hormone therapy-naïve for ≥6 months. Baseline evaluation included demographic data, reproductive history, prior surgeries, and six pain domains. #Enzian classification mapped lesion location and size (A: rectovaginal/vagina; B: uterosacral/parametria; C: rectum; FA: adenomyosis; FB: bladder; FU: ureter; FI: intestine above rectum; FO: extra pelvic; O: ovary; P: peritoneum; T: fallopian tubes/adhesions). Linear regression and linear mixed-effects models assessed associations between #Enzian compartments and pain trajectories. Results: Dysmenorrhea occurred in 86.5%, and dyspareunia occurred in 56.2%. Ovarian endometriomas (O) were present in 76.4%, deep infiltrating endometriosis (A, B, C) in 51.7%, and adenomyosis (FA) in 66.3%. POP-D was most effective in reducing ovulatory pain in ovarian (O), uterosacral/parametria (B), rectal (C), and tubal/adhesion (T) involvement, while EP-D was superior for dyspareunia in T. Chronic pelvic pain (CPP) remained refractory. Higher total #Enzian scores correlated with reduced therapy efficacy. Limitations: Retrospective design, single-center, small sample, use of aggregated pain scores, and incomplete follow-up may limit generalizability. Conclusion: Ultrasound-based #Enzian classification correlates with lesion distribution and predicts hormonal therapy efficacy. POP-D therapy is superior at lower #Enzian scores; CPP remains challenging. Findings support individualized medical management and warrant prospective validation including multidimensional pain and quality-of-life assessments.